Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice-based research network

Journal of Clinical Pharmacy and Therapeutics
Mylène ChartrandLine Guénette

Abstract

The literature has reported suboptimal real-world use of oral anticoagulants in patients with atrial fibrillation (AF). Anticoagulation management services (AMSs) in community pharmacy have rarely been evaluated, and no formal process is available to enable pharmacists to evaluate and improve their clinical practices. Our objective was to assess the feasibility of implementing, through a practice-based research network (PBRN), a quality improvement programme on AMSs by community pharmacists for AF patients and explore its impact on the quality of clinical practices and pharmacists' knowledge. An uncontrolled pre/post-pilot study was conducted through a PBRN. Pharmacists identified 5-20 AF patients on oral anticoagulants per pharmacy and completed questionnaires at baseline (T0) and after 6 months (T6). Clinical practices were evaluated using a set of quality indicators (QIs). QI scores ranged from 0% (no QI achieved) to 100% (all QIs achieved). The programme included an audit and feedback based on QIs and a personalized training programme (including online videos). Participation rates and satisfaction were documented. Mean changes (T6-T0), with 95% confidence interval (CI), in QIs and knowledge scores were computed. A total of ...Continue Reading

References

Jun 11, 1999·Journal of the American Pharmaceutical Association : APhA·C H KnowltonS A Zarus
Feb 13, 2004·Health Technology Assessment : HTA·J M GrimshawC Donaldson
Sep 18, 2004·Journal of the American Pharmacists Association : JAPhA·Nadia A Amruso
Mar 4, 2006·Pharmacoepidemiology and Drug Safety·Susan E AndradeK Arnold Chan
Apr 15, 2009·Circulation·Henry H TingElizabeth H Bradley
Jul 9, 2010·The American Journal of Medicine·Isla M OgilvieGregory Y H Lip
Jul 15, 2011·Journal of the American Pharmacists Association : JAPhA·William R DoucetteDavid P Nau
Sep 8, 2012·Journal of the American Board of Family Medicine : JABFM·Kevin A PetersonSteve Durako
Jun 26, 2013·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Joanie HébertLyne Lalonde
Sep 25, 2014·The International Journal of Pharmacy Practice·Jeff HarrisonJenny E Harrison
Mar 27, 2015·BMJ Quality & Safety·Margareth Crisóstomo PortelaMary Dixon-Woods
Apr 15, 2015·JAMA : the Journal of the American Medical Association·Supriya ShoreMintu P Turakhia
Feb 11, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Endalkachew A AlamnehLuke R Bereznicki
Oct 28, 2016·Journal of Clinical Pharmacy and Therapeutics·S Cerqueira SantosD P de Lyra
Nov 11, 2016·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Ariane CantinLyne Lalonde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.